Current Studies Seeking Participants
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Sponsor: Boston Children's Hospital
Collaborator: Boston Children's Hospital - Children's Rare Disease Cohorts Initiative
Information provided by (Responsible Party): Darius Ebrahimi-Fakhari, Boston Children's Hospital
The purpose of the HSP Sequencing Initiative is to better understand the role of genetics in hereditary spastic paraplegia (HSP) and related disorders. The HSPs are a group of more than 80 inherited neurological diseases that share the common feature of progressive spasticity. Collectively, the HSPs present the most common cause of inherited spasticity and associated disability, with a combined prevalence of 2-5 cases per 100,000 individuals worldwide.
In childhood-onset forms, initial symptoms are often non-specific and many children may not receive a diagnosis until progressive features are recognized, often leading to a significant diagnostic delay. Genetic testing in children with spastic paraplegia is not yet standard practice. In this study, the investigators hope to identify genetic factors related to HSP. By identifying different genetic factors, the investigators hope that we can develop better treatments for sub-categories of HSP based on cause over time.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. Explore 330,850 research studies in all 50 states and in 209 countries.
ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine.
The National Institutes of Health (NIH) Clinical Center Search the Studies site is a registry of publicly supported clinical studies conducted mostly in Bethesda, MD.
Answer some questions and how far you are willing to travel. It's EASY!